Optipharm.CO.LTD (153710) — Financial Flexibility Index
Optipharm.CO.LTD (153710) has a Financial Flexibility Index of 0.07x as of June 2026. Free cash flow of ₩1.04 Billion (operating CF ₩905.29 Million minus capex ₩130.67 Million) represents 0% of total liabilities (₩15.42 Billion). Check Optipharm.CO.LTD cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Optipharm.CO.LTD Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Optipharm.CO.LTD across 11 annual periods. For the full cash flow conversion analysis, see Optipharm.CO.LTD cash conversion from operations.
Annual Financial Flexibility Index for Optipharm.CO.LTD (2015–2025)
Year-by-year free cash flow to debt coverage for Optipharm.CO.LTD. Explore Optipharm.CO.LTD cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.06x | ₩990.05 Million | ₩-1.55 Billion | ₩15.37 Billion | ▼ -9.7% |
| 2024 | 0.07x | ₩1.14 Billion | ₩-595.50 Million | ₩15.98 Billion | ▲ +6829.7% |
| 2023 | 0.00x | ₩14.55 Million | ₩-1.72 Billion | ₩14.13 Billion | ▼ -99.4% |
| 2022 | 0.18x | ₩2.17 Billion | ₩-2.43 Billion | ₩12.17 Billion | ▲ +250.2% |
| 2021 | -0.12x | ₩-1.21 Billion | ₩-1.97 Billion | ₩10.21 Billion | ▼ -23.3% |
| 2020 | -0.10x | ₩-725.76 Million | ₩-1.62 Billion | ₩7.54 Billion | ▼ -154.8% |
| 2019 | 0.18x | ₩1.07 Billion | ₩447.47 Million | ₩6.11 Billion | ▼ -10.1% |
| 2018 | 0.20x | ₩1.41 Billion | ₩1.20 Billion | ₩7.20 Billion | ▲ +48.1% |
| 2017 | 0.13x | ₩931.19 Million | ₩260.86 Million | ₩7.06 Billion | ▼ -25.5% |
| 2016 | 0.18x | ₩1.25 Billion | ₩861.36 Million | ₩7.08 Billion | ▲ +479.7% |
| 2015 | -0.05x | ₩-611.90 Million | ₩-751.51 Million | ₩13.12 Billion | — |